Dean Murphy, RAC

Vice President of Regulatory Affairs and Quality Assurance

Dean Murphy, RAC, is Vice President of Regulatory Affairs and Quality Assurance at NeuroTrauma Sciences. With more than 30 years’ experience in the biopharmaceutical and medical device industries, he has provided strategic and tactical regulatory direction along with quality compliance for all aspects of research and development and has successfully established and maintained state-of-the-art regulatory, quality assurance and compliance programs for emerging and Fortune 500 companies. He has had extensive interaction with regulatory agencies (FDA, EMA) and develops pragmatic, innovative strategies and global regulatory programs relating to GxP (GLP, GCP and GMP), ISO and best business/regulatory practices. Dean’s prior experience ranges from start-ups, including Alteon, Pharmacopeia/Ligand through several multi-national large biopharmaceutical and device companies, including Wyeth, Glaxo, Novartis, Hoffman-La Roche, and Johnson &Johnson. Dean graduated from Stockton State College, Pomona, NJ, with a B.S. in Biology.